SOCS3 and obesity disorder: Socs3 is upregulated in obesity and inhibits leptin and insulin signaling (Palanivel et al., 2012), while its downregulation reduces hepatic lipid levels in obese Sprague–Dawley rats (Jiang et al., 2024).